Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D3SW
|
|||
Former ID |
DIB010457
|
|||
Drug Name |
ABX-103
|
|||
Synonyms |
Anticancer antibody (3), Abxign
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
Abxign Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H18BrN3O4
|
|||
Canonical SMILES |
C1C(OC(=O)N1C2=CC3=C(COCC4=CC=CN43)C=C2)CNC(=O)CBr
|
|||
InChI |
1S/C18H18BrN3O4/c19-7-17(23)20-8-15-9-22(18(24)26-15)13-4-3-12-10-25-11-14-2-1-5-21(14)16(12)6-13/h1-6,15H,7-11H2,(H,20,23)/t15-/m0/s1
|
|||
InChIKey |
JSSIINUBMRUCIW-HNNXBMFYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.